NCT05422105View on ClinicalTrials.gov

Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient

UnknownOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Prostate CancerProstate Neoplasm
Interventions
DRUG

18F-PSMA-1007

18F-PSMA-1007 PET/CT

Trial Locations (2)

111

RECRUITING

Shin Kong Wu Ho-Su Memorial Hospital, Taipei

43503

RECRUITING

Tungs'Taichung Metro Harbor Hospital, Taichung

Sponsors
All Listed Sponsors
collaborator

ABX advanced biochemical compounds GmbH

INDUSTRY

lead

Primo Biotechnology Co., Ltd

INDUSTRY